Aziz et al. (2016) have identified a gene signature which might be a reliable prognostic marker in CRC survival; among the genes linked with tumor development such as NOTCH2 or BRCA1, this set also included significantly decreased CERS6 in patient groups with poor prognosis of survival [26]. This evidence concerns the gene CERS6 and colorectal carcinoma.